The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Offer for Subscription

22 Sep 2017 18:25

RNS Number : 6312R
Maven Income & Growth VCT 4 PLC
22 September 2017
 

Joint Announcement

 

Offer for Subscription

 

22 September 2017

The board of directors of Maven Income and Growth VCT 3 PLC ("Maven VCT 3") and Maven Income and Growth VCT 4 PLC ("Maven VCT 4") (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in the Companies to raise, in aggregate, up to £30 million with over-allotment facilities of up to, in aggregate, a further £10 million (before issue costs) (the "Offers").

 

The Companies have also published a joint circular (the "Circular") seeking the approval of their respective shareholders for matters in connection with the Offers, each Company giving notice of a general meeting to be held on 8 November 2017 (the "General Meeting").

 

The Offers will open on 22 September 2017 and are expected to close no later than 3 April 2018 in relation to the tax year 2017/18 and on 20 April 2017 in relation to the tax year 2018/19 (unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant board to no later than 14 September 2018).

 

Each Offer is conditional on the passing of all the resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 22 September 2017 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of the Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the fee applying in certain cases (for instance, early applications under the Offers). Maven as the investment manager of each Company is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Further, William Nixon has expressed his intention, prior to the close of each of the Offers, to subscribe £50,000 in Maven VCT 3 and £50,000 in Maven VCT 4 under the relevant Offer. As a director of each of the Companies, William Nixon is a related party of the relevant Company under the Listing Rules and consequently each subscription is a transaction to which Listing Rule 11.1.10R applies.

Maven VCT 3 has also agreed with Maven that with effect from 1 December 2017 Maven will also be entitled to a performance incentive fee, for each six month period ending 31 May and 30 November, of an amount equal to 15% of any increase in the total return (before applying any performance incentive fee) as at the end of the relevant six month period to the total return (after accruing for the performance incentive fee payable for that period) compared to the end of the last six month period on which a performance incentive fee was paid. Payments in relation to any performance incentive fee shall not exceed £890,000 in relation to any rolling twelve month period ending on the date of the proposed payment. Maven and Maven VCT 3 have also agreed to vary the terms of a co-investment agreement (which enables employees and officers of Maven to co-invest with Maven VCT 3 in certain new and follow-on investments) with the effect that the 8% total investment limit (which applies to the investments that can be made by such employees and officers) will be reduced to 5% with effect from 1 December 2017. As Maven is a related party of Maven VCT 3 under the Listing Rules, the introduction of a performance incentive fee payable by that Company to Maven, together with the variation of the co-investment arrangements, are transactions to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven Capital Partners LLP on 0141 306 7400. A downloadable version of the Securities Note will also be available from the each of the Company's websites: http://www.mavencp.com/migvct3 and http://www.mavencp.com/migvct4 .

 

Copies of the Prospectus and Circular are available, free of charge, from Maven Capital Partners UK LLP at Kintyre House, 205 West George Street, Glasgow G2 2LW.

 

In accordance with the Listing Rules, the Prospectus and Circular have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

 

www.morningstar.co.uk/uk/NSM.

 

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLP

Telephone: 0141 306 7400E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLPSecretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRPGUWPBUPMGMP
Date   Source Headline
9th Nov 20223:02 pmRNSResult of General Meeting
7th Oct 20224:28 pmRNSPublication of a Prospectus
7th Oct 20229:58 amRNSDirector/PDMR Shareholding
7th Oct 20229:51 amRNSIssue of Equity
4th Oct 20223:30 pmRNSChange of Auditor
3rd Oct 20223:08 pmRNSStatement re Dividend Investment Scheme
6th Sep 20224:48 pmRNSTransaction in Own Shares
2nd Sep 20223:30 pmRNSHalf-year Report
19th Aug 202210:47 amRNSStatement re NAV and Interim Dividend
14th Jul 20229:33 amRNSDirectorate Change
8th Jul 20223:28 pmRNSStatement re Joint Offers for Subscription
24th Jun 20224:13 pmRNSDirectorate Change
9th Jun 20224:18 pmRNSTransaction in Own Shares
6th Jun 20222:15 pmRNSIssue of Equity
20th May 202210:09 amRNSDirector/PDMR Shareholding
20th May 202210:03 amRNSIssue of Equity
13th May 20223:24 pmRNSStatement re Dividend Investment Scheme
12th May 20223:19 pmRNSNet Asset Value(s)
11th May 20222:01 pmRNSResult of AGM & Directorate Change
26th Apr 202212:34 pmRNSIssue of Supplementary Prospectus
5th Apr 20226:30 pmRNSIssue of Equity
23rd Mar 20225:10 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:05 pmRNSIssue of Equity
22nd Mar 20223:23 pmRNSAnnual Financial Report
16th Mar 20223:32 pmRNSTransaction in Own Shares
15th Mar 20223:09 pmRNSTransaction in Own Shares
11th Mar 202211:41 amRNSIssue of Equity - Dividend Investment Scheme
10th Mar 202211:30 amRNSIssue of Equity
10th Mar 202211:20 amRNSStatement re Dividend Investment Scheme
10th Mar 202211:04 amRNSNet Asset Value and Proposed Final Dividend
18th Feb 20225:32 pmRNSIssue of Equity - Replacement Announcement
7th Feb 202212:49 pmRNSDirector/PDMR Shareholding
7th Feb 202212:48 pmRNSDirector/PDMR Shareholding
7th Feb 202210:51 amRNSIssue of Equity
4th Feb 20229:46 amRNSNet Asset Value(s)
31st Jan 20224:25 pmRNSStatement re Offer for Suscription
10th Jan 202212:43 pmRNSStatement re Offer for Subscription
5th Jan 202210:35 amRNSDividend Declaration
2nd Dec 20213:37 pmRNSTransaction in Own Shares
11th Nov 20213:25 pmRNSNet Asset Value(s)
20th Oct 20214:44 pmRNSResult of General Meeting
1st Oct 20219:22 amRNSIssue of Equity
28th Sep 20213:22 pmRNSStatement re Dividend Investment Scheme
20th Sep 20215:42 pmRNSStatement re Change of Registrar
20th Sep 20215:21 pmRNSPublication of a Prospectus
7th Sep 20214:47 pmRNSTransaction in Own Shares
31st Aug 20213:27 pmRNSTransaction in Own Shares
27th Aug 20213:23 pmRNSHalf-year Report
24th Aug 20213:42 pmRNSTransaction in Own Shares
23rd Aug 20213:14 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.